FDA Clearance Tracker · P980053-S021
Durasphere Injectable Bulking Agent
Last checked: Nov 20, 2026Latest source record: Mar 13, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Mar 13, 2026
Approved
Time to decision
414 days
Received Jan 23, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P980053-S021
- Device name
- Durasphere Injectable Bulking Agent
- Applicant
- Carbon Medical Technologies, Inc.
- Applicant location
- St. Paul, MN
- Received
- Jan 23, 2025
- Decided
- Mar 13, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P980053
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
a change to the syringe cap of the 1 mL Durasphere device configuration
Source documents
Other decisions for Carbon Medical Technologies, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253598 · Decided Mar 31, 2026 · 133 days after receipt
Device type: Endoscopic Injection Needle, Gastroenterology-Urology (FBK) · GI, Urology & Nephrology
K251748 · Decided Jul 23, 2025 · 47 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
- Fiducial Marker510(k)
K211590 · Decided Jun 10, 2021 · 17 days after receipt
Device type: Accelerator, Linear, Medical (IYE) · Radiology & Imaging
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.